• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MELODY TRANSCATHER PULMONARY VALVE; PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MELODY TRANSCATHER PULMONARY VALVE; PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number PB 10
Device Problems Fracture (1260); Occlusion Within Device (1423); Structural Problem (2506)
Patient Problems Death (1802); Endocarditis (1834); Pulmonary Regurgitation (2023); Stenosis (2263)
Event Date 03/23/2015
Event Type  Death  
Manufacturer Narrative
Conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation.No unique device identifier (serial/lot) numbers were provided; without this information it cannot be determined whether this event has been previously reported.(b)(4).Citation: title: the clinical and hemodynamic outcomes up to 7 years after transcatheter pulmonary valve replacement in the us melody valve in vestigational device exemption trial.Authors: john p.Cheatham, md; william e.Hellenbrand, md; evan m.Zahn, md; thomas k.Jones, md; darren p.Berman, md; julie a.Vincent, md; doff b.Mcelhinney, md journal: circulation.2015;131:1960-1970.
 
Event Description
Medtronic received information via literature review that a study was performed to evaluate the clinical and hemodynamic outcomes up to 7 years after transcatheter pulmonary valve replacement in the us melody valve investigational device exemption trial.The study population included 171 patients (mean age of 19 years), 150 of which were implanted with medtronic melody transcatheter pulmonary valve (tpv) (serial numbers not provided).Among all patients, 4 deaths occurred, which included: 1 of multisystem failure resulting from sepsis/endocarditis and 3 of other causes with no apparent relationship to the melody valve (1 of respiratory failure and 2 of unknown causes).Among all patients, 32 adverse events occurred, which included: 32 patients underwent right ventricular outflow tract reintervention for obstruction (n=27, with stent fracture in 22), endocarditis (n=3, 2 with stenosis and 1 with pulmonary regurgitation), or right ventricular dysfunction (n=2).Eleven patients had the tpv explanted as an initial or second reintervention, pulmonary hypertension and increasing rv pressures was also noted in one patient.Five-year freedom from reintervention and explantation was 76±4% and 92±3%, respectively.A conduit pre-stent and lower discharge right ventricular outflow tract gradient were associated with longer freedom from reintervention.In the 113 patients who were alive and reintervention free, the follow-up gradient (median, 4.5 years after implantation) was unchanged from early post-tpv replacement, and all but 1 patient had mild or less pulmonary regurgitation.Almost all patients were in new york heart association class i or ii.More severely impaired baseline spirometry was associated with a lower likelihood of improvement in exercise function after tpv replacement.Conclusions¿tpv replacement with the melody valve provided good hemodynamic and clinical outcomes up to 7 years after implantation.Primary valve failure was rare.The main cause of tpv dysfunction was stenosis related to stent fracture, which was uncommon once prestenting became more widely adopted.
 
Manufacturer Narrative
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MELODY TRANSCATHER PULMONARY VALVE
Type of Device
PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e. deere ave.
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC STRUCTURAL HEART
8200 coral sea street ne
mounds view MN 55112
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key5322572
MDR Text Key34240243
Report Number2025587-2015-01374
Device Sequence Number1
Product Code NPV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140017
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/25/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/23/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberPB 10
Device Catalogue NumberPB 10
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/25/2015
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Required Intervention;
Patient Age00019 YR
-
-